Numerous studies have shown that the overexpression of CCL2 amplifies many cancer cells’ motility and promotes tumor development and metastasis [32,33,34,35,36,37,38], such as chondrosarcoma [22], nasopharyngeal carcinoma [21], and breast carcinoma [23]. Here, CCL2 is linked to chondrosarcoma.